Results 51 to 60 of about 985,610 (254)

Emergency Physicians' Knowledge of Cannabinoid Designer Drugs

Western Journal of Emergency Medicine, 2013
Introduction: The use of synthetic drugs of abuse in the United States has grown in the last few years, with little information available on how much physicians know about these drugs and how they are treating patients using them.
Patrick M Lank, Elizabeth Pines, Mark B Mycyk   +2 more
doaj   +1 more source

Deaths linked to synthetic cannabinoids [PDF]

Forensic Science, Medicine, and Pathology, 2015
Over the last 5 years there has been an influx of novel designer drugs (mostly illegal) which are intended to mimic the effects of cannabis (synthetic cannabinoids). Many of these compounds are created by research groups attempting to find an analog of cannabis that can be used therapeutically to treat pain and other conditions.
Dimitri, Gerostamoulos, Olaf H, Drummer, Noel W, Woodford   +2 more
openaire   +2 more sources

Rapid Detection of Synthetic Cannabinoids in E-Cigarette Liquids Based on Miniature Ion Trap Mass Spectrometry

Zhipu Xuebao
In recent years, the misuse of synthetic cannabinoids has garnered significant societal attention. To evade regulation, synthetic cannabinoids are often illicitly mixed into e-cigarette liquids to create "heady e-cigarettes".
Ya-jin HE, Hui-wen RUAN, Ming-jian ZHANG, Wu-duo ZHAO, Gui-yun SONG, Ke ZHANG, Bing WANG, Suo-suo YANG, Jian KANG, Bin LI, Shuang WANG, Wei-guo WANG   +11 more
doaj   +1 more source

Perspectives on drugs: Synthetic cannabinoids in Europe. [PDF]

, 2015
Synthetic cannabinoids represent the largest group of compounds currently monitored in Europe by the EU Early warning system on new psychoactive substances. Current knowledge on these substances, as well as trends in production, availability and use, are

core  

Metabolic fate of drugs of abuse and new psychoactive substances: A pilot study on a novel workflow using a zebrafish embryo model combined with human microdosing

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study was to develop a novel workflow to identify human urine biomarkers for drugs of abuse and new psychoactive substances. Metabolites of amphetamine, cocaine, LSD, MDMA, methamphetamine, THC, MDMB‐CHMICA, and MDPPP were first identified in a zebrafish embryo (ZE) metabolism study followed by comparison to most abundant human ...
Simon K. Wellenberg, Tanja M. Gampfer, Lea Wagmann, Philip Schippers, Jennifer Herrmann, Rolf Müller, Folker Westphal, Markus R. Meyer   +7 more
wiley   +1 more source

A Forensic Analysis of Synthetic Cannabinoids [PDF]

, 2021
Synthetic cannabinoids are a drug produced in a laboratory designed to imitate the physiological and psychological effects of a specific controlled substance.
Bove, Gianna
core  

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source

Comparing Two Seized Drug Workflows for the Analysis of Synthetic Cannabinoids, Cathinones, and Opioids [PDF]

, 2021
As the challenges faced by drug chemists continue to persist due to the presence of synthetic opioids, novel psychoactive substances, and other emerging drugs, laboratories are continuing to look for new analytical approaches or techniques to ease the ...
Elizabeth, Schneider, Charles R., Miller IV, Amber, Burns, Edward, Sisco, Laurel, Bobka   +4 more
core   +1 more source

Synthetic cannabinoids impact on cognitive functions

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2023
Background Synthetic cannabinoids SC are now becoming progressively popular among young people worldwide; little is known about their negative effects.
Hanan Hany Elrassas, Yasser Abdel Razek Elsayed, Mai SeifElDin Abdeen, Aya Taha Mohamed, Zeinab Mohamed El Nagar   +4 more
doaj   +1 more source

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

Brain Sciences, 2023
Background: There is a growing liberalization of cannabis-based preparations for medical and recreational use. In multiple instances, anxiety and depression are cited as either a primary or a secondary reason for the use of cannabinoids. Aim: The purpose
Ahmed Hasbi, Bertha K. Madras, Susan R. George   +2 more
doaj   +1 more source